Trastuzumab Plus Docetaxel in Treating Women With Recurrent or Metastatic Breast Cancer
Phase 2
Completed
- Conditions
- First Posted Date
- 2003-12-24
- Last Posted Date
- 2012-08-14
- Lead Sponsor
- Vanderbilt-Ingram Cancer Center
- Target Recruit Count
- 46
- Registration Number
- NCT00006104
- Locations
- 🇺🇸
Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, United States
🇺🇸Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
🇺🇸St. Thomas Health Services, Nashville, Tennessee, United States
© Copyright 2024. All Rights Reserved by MedPath